Replication of the GRADE Diabetes Trial in Healthcare Claims Data

CompletedOBSERVATIONAL

Enrollment

6,403

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions

Diabetes

Interventions

DRUG

Sitagliptin

Sitagliptin dispensing claim is used as the reference

DRUG

Glimepiride

Glimepiride dispensing claim is used as the reference

Trial Locations (1)

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT05099198 - Replication of the GRADE Diabetes Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter